05.11.2012 Views

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>of</strong> one type <strong>of</strong> treatment can be better extended to cl<strong>in</strong>ical practice, have become<br />

necessary for chronic diseases such as asthma (Bjermer 2006). At present, no such<br />

studies have appeared on AD.<br />

Table 1. Studies on the most common treatments <strong>of</strong> AD <strong>in</strong>clud<strong>in</strong>g only those with<br />

ef<strong>fi</strong>cacy >50%.<br />

Treatment Ef<strong>fi</strong>cacy <strong>in</strong> placebo-controlled short-term<br />

studies ( < 6 months)<br />

<strong>Topical</strong><br />

steroids<br />

UV-light<br />

treatments<br />

Betamethasone dipropionate (Vanderploeg<br />

1976)<br />

Clobetasol propionate (Maloney et al. 1998)<br />

Desonide (Stalder et al. 1994)<br />

Halc<strong>in</strong>onide (Lupton et al. 1982)<br />

Hydrocortisone buteprate (Sears et al. 1997)<br />

Hydrocortisone valerate (Sefton et al. 1984)<br />

Fluticasone propionate (Lebwohl et al. 1996)<br />

Fluticasone propionate <strong>in</strong> ma<strong>in</strong>tenance therapy<br />

twice weekly (Berth-Jones et al. 2003)<br />

Broad band UVB (Jekler & Larkö 1988)<br />

Narrow band UVB, UVA (Reynolds et al. 2001)<br />

Ciclospor<strong>in</strong> 5 mg/kg (Munro et al. 1994, Salek et al. 1993,<br />

Sowden et al. 1991, van Joost et al. 1994,<br />

Wahlgren et al. 1990)<br />

Systemic<br />

steroids<br />

32<br />

Ef<strong>fi</strong>cacy <strong>in</strong> controlled long-term studies<br />

( � 6 months)<br />

Fluticasone propionate vs. vehicle <strong>in</strong><br />

ma<strong>in</strong>tenance therapy twice weekly (Hanif<strong>in</strong> et al.<br />

2002)<br />

Unavailable<br />

Unavailable Unavailable<br />

Methotrexate Unavailable Unavailable<br />

Azathiopr<strong>in</strong>e Unavailable Unavailable<br />

Tacrolimus<br />

o<strong>in</strong>tment<br />

Pimecrolimus<br />

cream<br />

0.03% <strong>in</strong> children (Schachner et al. 2005)<br />

0.03% <strong>in</strong> adults and children (Chapman et al.<br />

2005)<br />

0.1% and 0.03% <strong>in</strong> adults and children (Hanif<strong>in</strong><br />

et al. 2001, Paller et al. 2001)<br />

0.03%, 0.1%, and 0.3% <strong>in</strong> adults and children<br />

(Ruzicka et al. 1997, Boguniewicz et al. 1998)<br />

Adults (Eichen<strong>fi</strong>eld et al. 2002)<br />

Children (Ho et al. 2003)<br />

3 mg/kg vs. 5mg/kg (Zonneveld et al. 1996)<br />

Short courses vs. cont<strong>in</strong>uous (Harper et al. 2000)<br />

0.1% <strong>tacrolimus</strong> vs. hydrocortisone 17-butyrate/<br />

hydrocortisone (Reitamo et al. 2005)<br />

Pimecrolimus vs. vehicle <strong>in</strong> adults, flare control<br />

(Meurer et al. 2002, 2004)<br />

Pimecrolimus vs. vehicle <strong>in</strong> children, flare control<br />

(Wahn et al. 2002, Kapp et al. 2002, Papp et al.<br />

2004)<br />

Pimecrolimus vs. triamc<strong>in</strong>olone acetate /<br />

hydrocortisone (Luger et al. 2004) (No <strong>in</strong>tentionto-treat<br />

analysis)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!